ALLO – allogene therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ALLO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/9

07:00 am

ALLO

Allogene Therapeutics (NASDAQ:ALLO) was upgraded by analysts at Citigroup Inc. from a "market perform" rating to an "outperform" rating.

Medium Report

Allogene Therapeutics (NASDAQ:ALLO) was upgraded by analysts at Citigroup Inc. from a "market perform" rating to an "outperform" rating.

Report

1/9

06:10 am

ALLO

Allogene Therapeutics (NASDAQ:ALLO) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.

Medium Report

Allogene Therapeutics (NASDAQ:ALLO) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.

Report

1/7

03:15 pm

ALLO

Rating for ALLO

Low Report

Rating for ALLO

Report

1/7

09:07 am

ALLO

Allogene Therapeutics (NASDAQ:ALLO) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.

Medium Report

Allogene Therapeutics (NASDAQ:ALLO) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.

Report

1/7

08:18 am

ALLO

Allogene Therapeutics initiated with a Buy at UBS

Medium Report

Allogene Therapeutics initiated with a Buy at UBS

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.